NSETrading Window29 Jun 2026 · 29 Jun 2026, 12:34 pm

Trading Window

Dr. Lal Path Labs Ltd. · LALPATHLAB

✦ AI SummaryMgmt Change

Dr. Lal Path Labs Ltd. has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the Board meeting to consider un-audited financial results for the quarter ending June 30, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Dr. Lal Path Labs Ltd. has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

LALPATHLAB_29062026123349_priorintimation24072026.pdf

pdf

Download →
View document text
June 29, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Corporate Relationship Department Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (E) Dalal Street Mumbai – 400 051 Mumbai – 400 001 Symbol: LALPATHLAB Scrip Code: 539524 Sub: Intimation of Board Meeting and Closure of Trading Window Ref: Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/ Madam, This is to inform you that a meeting of the Board of Directors is scheduled to be held on Friday, July 24, 2026 to inter-alia consider and approve the un-audited (Standalone & Consolidated) Financial Results of the Company for the Quarter ending on June 30, 2026. Further, in accordance with the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code for Prevention of Insider Trading, the Trading Window for dealing in Securities of the Company shall be closed from July 1, 2026, to July 26, 2026 (both days inclusive). We request you to kindly take the same on record. Thanking You, Yours Faithfully, For Dr. Lal PathLabs Limited Vinay Gujral Company Secretary & Compliance Officer